Vidcast:  https://youtu.be/8YDcbnYmuhI

 

#1: Ninety-seven percent of patients with moderate to severe CoVid quickly recovered from the disease with inhalation therapy using the experimental agent EXO-CD24.  Israeli investigators report the results of a preliminary but exciting phase one study involving 30 patients,

 

The agent, inhaled daily for 5 days, uses exosomes to deliver the immunoregulatory protein CD24 straight to the lungs.  The treatment tamps down the CoVid-generated cytokine storm.  Larger trials are now underway.

 

Agent #2: British researchers conclude that the asthma inhaled steroid, budesonide,used by asthmatics, stops CoVid progression in 90% of patients.   A total of 139 patients were randomized to receive the steroid or conventional therapy.  The treated group was less symptomatic.

 

https://www.timesofisrael.com/new-israeli-drug-cured-moderate-to-serious-covid-cases-within-days-hospital/

https://www.medrxiv.org/content/10.1101/2021.02.04.21251134v1.full.pdf+html

 

#CoVid #cytokinestorm #exocd24 #budesonide #inhalation

CoVid, cytokinestorm, exocd24, budesonide, inhalation